{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T10:42:07Z","timestamp":1795084927748,"version":"4.10.2"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T00:00:00Z","timestamp":1557100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009794","name":"Breast Cancer Now","doi-asserted-by":"publisher","award":["Breast Cancer Campaign 2011NovPR49"],"award-info":[{"award-number":["Breast Cancer Campaign 2011NovPR49"]}],"id":[{"id":"10.13039\/100009794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000764","name":"Kings College London","doi-asserted-by":"publisher","award":["King\u2019s Health Partner\u2019s Research and Development Challenge Fund (R150505)"],"award-info":[{"award-number":["King\u2019s Health Partner\u2019s Research and Development Challenge Fund (R150505)"]}],"id":[{"id":"10.13039\/501100000764","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["8873"],"award-info":[{"award-number":["8873"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13058-019-1143-y","type":"journal-article","created":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T15:00:10Z","timestamp":1557154810000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50\u2009years"],"prefix":"10.1186","volume":"21","author":[{"given":"Christos","family":"Petridis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iteeka","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandna","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anargyros","family":"Megalios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca","family":"Mera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Clifford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Gillett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Pinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Roylance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8285-4111","authenticated-orcid":false,"given":"Elinor J.","family":"Sawyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,6]]},"reference":[{"issue":"9","key":"1143_CR1","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/sj.bjc.6605655","volume":"102","author":"H Wong","year":"2010","unstructured":"Wong H, Lau S, Yau T, Cheung P, Epstein RJ. Presence of an in situ component is associated with reduced biological aggressiveness of size-matched invasive breast cancer. Br J Cancer. 2010;102(9):1391\u20136.","journal-title":"Br J Cancer"},{"issue":"2","key":"1143_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s10552-015-0696-z","volume":"27","author":"M Ruszczyk","year":"2016","unstructured":"Ruszczyk M, Zirpoli G, Kumar S, Bandera EV, Bovbjerg DH, Jandorf L, Khoury T, Hwang H, Ciupak G, Pawlish K, et al. Breast cancer risk factor associations differ for pure versus invasive carcinoma with an in situ component in case-control and case-case analyses. Cancer Cause Control. 2016;27(2):183\u201398.","journal-title":"Cancer Cause Control"},{"issue":"10","key":"1143_CR3","doi-asserted-by":"crossref","first-page":"7597","DOI":"10.18632\/oncotarget.3162","volume":"6","author":"SY Kim","year":"2015","unstructured":"Kim SY, Jung SH, Kim MS, Baek IP, Lee SH, Kim TM, Chung YJ, Lee SH. Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer. Oncotarget. 2015;6(10):7597\u2013607.","journal-title":"Oncotarget"},{"issue":"3","key":"1143_CR4","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1007\/s12032-011-0082-y","volume":"29","author":"H Wong","year":"2012","unstructured":"Wong H, Lau S, Leung R, Chiu J, Cheung P, Wong TT, Liang R, Epstein RJ, Yau T. Coexisting ductal carcinoma in situ independently predicts lower tumor aggressiveness in node-positive luminal breast cancer. Med Oncol. 2012;29(3):1536\u201342.","journal-title":"Med Oncol"},{"issue":"4","key":"1143_CR5","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1158\/1055-9965.EPI-04-0849","volume":"14","author":"CI Li","year":"2005","unstructured":"Li CI, Daling JR, Malone KE. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001. Cancer Epidem Biomar. 2005;14(4):1008\u201311.","journal-title":"Cancer Epidem Biomar"},{"issue":"12","key":"1143_CR6","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1093\/jnci\/djh164","volume":"96","author":"GD Leonard","year":"2004","unstructured":"Leonard GD, Swain SM. Ductal carcinoma in situ, complexities and challenges. J Natl Cancer Inst. 2004;96(12):906\u201320.","journal-title":"J Natl Cancer Inst"},{"issue":"23","key":"1143_CR7","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1093\/jnci\/93.23.1811","volume":"93","author":"EB Claus","year":"2001","unstructured":"Claus EB, Stowe M, Carter D. Breast carcinoma in situ: risk factors and screening patterns. J Natl Cancer Inst. 2001;93(23):1811\u20137.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"1143_CR8","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1002\/ijc.26460","volume":"131","author":"GK Reeves","year":"2012","unstructured":"Reeves GK, Pirie K, Green J, Bull D, Beral V, Million Women Study C. Comparison of the effects of genetic and environmental risk factors on in situ and invasive ductal breast cancer. Int J Cancer. 2012;131(4):930\u20137.","journal-title":"Int J Cancer"},{"issue":"1","key":"1143_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1023\/A:1022147920262","volume":"78","author":"EB Claus","year":"2003","unstructured":"Claus EB, Stowe M, Carter D. Family history of breast and ovarian cancer and the risk of breast carcinoma in situ. Breast Cancer Res Treat. 2003;78(1):7\u201315.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"1143_CR10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/jnci\/89.1.76","volume":"89","author":"K Kerlikowske","year":"1997","unstructured":"Kerlikowske K, Barclay J, Grady D, Sickles EA, Ernster V. Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer. J Natl Cancer Inst. 1997;89(1):76\u201382.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"1143_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13058-016-0675-7","volume":"18","author":"C Petridis","year":"2016","unstructured":"Petridis C, Brook MN, Shah V, Kohut K, Gorman P, Caneppele M, Levi D, Papouli E, Orr N, Cox A, et al. Genetic predisposition to ductal carcinoma in situ of the breast. Breast Cancer Res. 2016;18(1):22.","journal-title":"Breast Cancer Res"},{"issue":"8","key":"1143_CR12","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1001\/jama.293.8.964","volume":"293","author":"EB Claus","year":"2005","unstructured":"Claus EB, Petruzella S, Matloff E, Carter D. Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ. JAMA. 2005;293(8):964\u20139.","journal-title":"JAMA"},{"issue":"12","key":"1143_CR13","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1158\/1940-6207.CAPR-09-0218","volume":"3","author":"MJ Hall","year":"2010","unstructured":"Hall MJ, Reid JE, Wenstrup RJ. Prevalence of BRCA1 and BRCA2 mutations in women with breast carcinoma in situ and referred for genetic testing. Cancer Prev Res. 2010;3(12):1579\u201385.","journal-title":"Cancer Prev Res"},{"issue":"10","key":"1143_CR14","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.5858\/133.10.1515","volume":"133","author":"SC Lester","year":"2009","unstructured":"Lester SC, Bose S, Chen YY, Connolly JL, de Baca ME, Fitzgibbons PL, Hayes DF, Kleer C, O'Malley FP, Page DL, et al. Protocol for the examination of specimens from patients with invasive carcinoma of the breast. Arch Pathol Lab Med. 2009;133(10):1515\u201338.","journal-title":"Arch Pathol Lab Med"},{"key":"1143_CR15","doi-asserted-by":"publisher","first-page":"7983236","DOI":"10.1155\/2016\/7983236","volume":"2016","author":"JD Hintzsche","year":"2016","unstructured":"Hintzsche JD, Robinson WA, Tan AC. A survey of computational tools to analyze and interpret whole exome sequencing data. Int J Genomics. 2016;2016:7983236.","journal-title":"Int J Genomics"},{"issue":"4","key":"1143_CR16","doi-asserted-by":"publisher","first-page":"e1004873","DOI":"10.1371\/journal.pcbi.1004873","volume":"12","author":"E Talevich","year":"2016","unstructured":"Talevich E, Shain AH, Botton T, Bastian BC. CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing. PLoS Comput Biol. 2016;12(4):e1004873.","journal-title":"PLoS Comput Biol"},{"issue":"24","key":"1143_CR17","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1093\/bioinformatics\/btu436","volume":"30","author":"V Boeva","year":"2014","unstructured":"Boeva V, Popova T, Lienard M, Toffoli S, Kamal M, Le Tourneau C, Gentien D, Servant N, Gestraud P, Rio Frio T, et al. Multi-factor data normalization enables the detection of copy number aberrations in amplicon sequencing data. Bioinformatics. 2014;30(24):3443\u201350.","journal-title":"Bioinformatics"},{"issue":"24","key":"1143_CR18","doi-asserted-by":"publisher","first-page":"5534","DOI":"10.1200\/JCO.2005.04.038","volume":"23","author":"PJ Chuba","year":"2005","unstructured":"Chuba PJ, Hamre MR, Yap J, Severson RK, Lucas D, Shamsa F, Aref A. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol. 2005;23(24):5534\u201341.","journal-title":"J Clin Oncol"},{"issue":"6","key":"1143_CR19","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/humu.10081","volume":"19","author":"M Olivier","year":"2002","unstructured":"Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P. The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat. 2002;19(6):607\u201314.","journal-title":"Hum Mutat"},{"issue":"12","key":"1143_CR20","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/jama.2018.13152","volume":"320","author":"J Mersch","year":"2018","unstructured":"Mersch J, Brown N, Pirzadeh-Miller S, Mundt E, Cox HC, Brown K, Aston M, Esterling L, Manley S, Ross T. Prevalence of variant reclassification following hereditary cancer genetic testing. JAMA. 2018;320(12):1266\u201374.","journal-title":"JAMA"},{"issue":"1","key":"1143_CR21","doi-asserted-by":"publisher","first-page":"a001008","DOI":"10.1101\/cshperspect.a001008","volume":"2","author":"M Olivier","year":"2010","unstructured":"Olivier M, Hollstein M, Hainaut P. TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb Perspect Biol. 2010;2(1):a001008.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"9","key":"1143_CR22","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/humu.23035","volume":"37","author":"L Bouaoun","year":"2016","unstructured":"Bouaoun L, Sonkin D, Ardin M, Hollstein M, Byrnes G, Zavadil J, Olivier M. TP53 variations in human cancers: new lessons from the IARC TP53 database and genomics data. Hum Mutat. 2016;37(9):865\u201376.","journal-title":"Hum Mutat"},{"key":"1143_CR23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s12967-015-0698-3","volume":"13","author":"RL Yang","year":"2015","unstructured":"Yang RL, Mick R, Lee K, Graves HL, Nathanson KL, Domchek SM, Kelz RR, Zhang PJ, Czerniecki BJ. DCIS in BRCA1 and BRCA2 mutation carriers: prevalence, phenotype, and expression of oncodrivers C-MET and HER3. J Transl Med. 2015;13:335.","journal-title":"J Transl Med"},{"issue":"3","key":"1143_CR24","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s10549-017-4198-4","volume":"163","author":"J Krammer","year":"2017","unstructured":"Krammer J, Pinker-Domenig K, Robson ME, Gonen M, Bernard-Davila B, Morris EA, Mangino DA, Jochelson MS. Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat. 2017;163(3):565\u201371.","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"1143_CR25","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.ejso.2015.01.021","volume":"41","author":"F Aloraifi","year":"2015","unstructured":"Aloraifi F, Alshehhi M, McDevitt T, Cody N, Meany M, O'Doherty A, Quinn CM, Green AJ, Bracken A, Geraghty JG. Phenotypic analysis of familial breast cancer: comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer. Eur J Surg Oncol. 2015;41(5):641\u20136.","journal-title":"Eur J Surg Oncol"},{"issue":"23","key":"1143_CR26","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1200\/JCO.2016.66.5844","volume":"34","author":"MK Schmidt","year":"2016","unstructured":"Schmidt MK, Hogervorst F, van Hien R, Cornelissen S, Broeks A, Adank MA, Meijers H, Waisfisz Q, Hollestelle A, Schutte M, et al. Age- and tumor subtype-specific breast cancer risk estimates for CHEK2*1100delC carriers. J Clin Oncol. 2016;34(23):2750\u201360.","journal-title":"J Clin Oncol"},{"issue":"9","key":"1143_CR27","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jamaoncol.2017.0424","volume":"3","author":"FJ Couch","year":"2017","unstructured":"Couch FJ, Shimelis H, Hu C, Hart SN, Polley EC, Na J, Hallberg E, Moore R, Thomas A, Lilyquist J, et al. Associations between cancer predisposition testing panel genes and breast cancer. JAMA Oncol. 2017;3(9):1190\u20136.","journal-title":"JAMA Oncol"},{"issue":"1","key":"1143_CR28","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/bjc.2013.295","volume":"109","author":"ZL Teo","year":"2013","unstructured":"Teo ZL, Provenzano E, Dite GS, Park DJ, Apicella C, Sawyer SD, James PA, Mitchell G, Trainer AH, Lindeman GJ, et al. Tumour morphology predicts PALB2 germline mutation status. Br J Cancer. 2013;109(1):154\u201363.","journal-title":"Br J Cancer"},{"issue":"6","key":"1143_CR29","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa1400382","volume":"371","author":"AC Antoniou","year":"2014","unstructured":"Antoniou AC, Casadei S, Heikkinen T, Barrowdale D, Pylkas K, Roberts J, Lee A, Subramanian D, De Leeneer K, Fostira F, et al. Breast-cancer risk in families with mutations in PALB2. N Engl J Med. 2014;371(6):497\u2013506.","journal-title":"N Engl J Med"},{"issue":"3","key":"1143_CR30","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s10549-012-1993-9","volume":"133","author":"S Masciari","year":"2012","unstructured":"Masciari S, Dillon DA, Rath M, Robson M, Weitzel JN, Balmana J, Gruber SB, Ford JM, Euhus D, Lebensohn A, et al. Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort. Breast Cancer Res Treat. 2012;133(3):1125\u201330.","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"1143_CR31","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/sj.bjc.6605606","volume":"102","author":"DG Evans","year":"2010","unstructured":"Evans DG, Moran A, Hartley R, Dawson J, Bulman B, Knox F, Howell A, Lalloo F. Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1\/BRCA2\/TP53 status. Br J Cancer. 2010;102(7):1091\u20138.","journal-title":"Br J Cancer"},{"issue":"21","key":"1143_CR32","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1200\/JCO.2014.59.5728","volume":"33","author":"G Bougeard","year":"2015","unstructured":"Bougeard G, Renaux-Petel M, Flaman J-M, Charbonnier C, Fermey P, Belotti M, Gauthier-Villars M, Stoppa-Lyonnet D, Consolino E, Brugi\u00e8res L, et al. Revisiting Li-Fraumeni syndrome from TP53 mutation carriers. J Clin Oncol. 2015;33(21):2345\u201352.","journal-title":"J Clin Oncol"},{"key":"1143_CR33","doi-asserted-by":"publisher","unstructured":"Schmidt MK, van den Broek AJ, Tollenaar RA, Smit VT, Westenend PJ, Brinkhuis M, Oosterhuis WJ, Wesseling J, Janssen-Heijnen ML, Jobsen JJ, et al. Breast cancer survival of BRCA1\/BRCA2 mutation carriers in a hospital-based cohort of young women. J Natl Cancer Inst. 2017;109(8):djw329. https:\/\/doi.org\/10.1093\/jnci\/djw329 .","DOI":"10.1093\/jnci\/djw329"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-019-1143-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13058-019-1143-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-019-1143-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T11:20:41Z","timestamp":1663413641000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-019-1143-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,6]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1143"],"URL":"https:\/\/doi.org\/10.1186\/s13058-019-1143-y","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,6]]},"assertion":[{"value":"6 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients and controls were recruited through the following ethically approved studies and gave consent to genetic testing (GLACIER study, MREC 06\/Q1702\/64; ICICLE, MREC 08\/H0502\/4; King\u2019s Health Partners breast tissue bank, NHS REC ref.-EE-0493).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there is no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"58"}}